Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel.
Saved in:
| Title: | Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel. |
|---|---|
| Authors: | Shagera QA; From the Departments of Nuclear Medicine., Karfis I; From the Departments of Nuclear Medicine., Sideris S; Oncology., Guiot T; From the Departments of Nuclear Medicine., Woff E; From the Departments of Nuclear Medicine., Martinez-Chanza N; Oncology., Roumeguere T; Urology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Gil T; Oncology., Flamen P; From the Departments of Nuclear Medicine., Artigas C; From the Departments of Nuclear Medicine. |
| Source: | Clinical nuclear medicine [Clin Nucl Med] 2023 Sep 01; Vol. 48 (9), pp. 775-780. Date of Electronic Publication: 2023 Jun 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1536-0229 |
|---|---|
| DOI: | 10.1097/RLU.0000000000004763 |
